Trial Profile
Antihypertensive, renal, inflammatory and oxidative stress effects of amlodipine and azelnidipine in patients with essential hypertensive
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Nov 2012
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Azelnidipine (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 15 Nov 2012 New trial record
- 04 Oct 2012 Results presented at the 24th Scientific Meeting of the International Society of Hypertension.